… the Company is providing second quarter 2025 guidance: net sales … a leading online pet pharmacy, in its family of … , financial guidance for second quarter 2025 and fiscal 2025 … flows from investing activities:       Capital expenditures   (141,280 )     (157, …

… will ramp as the second quarter progresses. Providing approximately $ … -period savings supporting the second quarter. As previously shared, … energy, home care, and pharma end markets. Data centers, … approaching a big capital expenditure for a lifetime extension …

First Quarter Highlights† Reported revenue of $355.4 million, up 9.8% Constant currency revenue* and constant currency revenue, organic* up 10.9% and up 6.0%, respectively GAAP operating margin of 11.5%, compared to 11.1% in prior year period Non-GAAP …

… to continue through the second quarter,” said Douglas T. … , including household, food and pharmaceutical, paper, packaging, automotive, … from operations less capital expenditures. The following is … available for discretionary expenditures since the Company …

… of launches slated for Q2, including those that will … $350 million of net capital expenditures. During Q1, we deployed … we interact obviously with our pharmaceutical and biotech customers continually. … to updating you on our second quarter results in July. And …

… operating cash flow minus capital expenditures) was $58.1 … the accompanying tables. WEST PHARMACEUTICAL SERVICES, INC. CONSOLIDATED … asset acquired during the second quarter of 2020. During the … in Daikyo.   WEST PHARMACEUTICAL SERVICES RECONCILIATION OF NON- …

… to 88 in the second quarter, and dropped to 83 … room for unverified tax expenditure figures in different quarters. … when analysing the Tax Expenditures in terms of … include manufacturing, solid material, pharmaceuticals, information and communication, trade, …

… enrollment completion expected in Q2 2025, with top … trials enrollment in the second quarter of 2025, with … expenses and capital expenditure requirements. Special consideration … the assessment of preclinical, pharmacokinetic, carcinogenicity, toxicity, …

… .5 billion and capital expenditures are expected to be … because the first and second quarter were really still impacted … That business is primarily serving pharmaceutical companies, CROs. It serves … seasonality. So EPS in Q2 being the highest quarter, …

… announcements from chips and pharmaceutical manufacturers. But we’ll … anniversarying those here in the second quarter. While there are ongoing … flow and disciplined net capital expenditures. Our current leverage ratio … talked about last year Q2. So that was a …